At the heart of Kindeva Drug Delivery is a profound commitment to 'Manufacture More Tomorrows' for patients around the globe. Born from a legacy of innovation that spans over a century, Kindeva emerged as an independent global force in 2020, spinning off from 3M Drug Delivery Systems. This heritage is not just a history lesson; it is the foundation of a culture deeply rooted in scientific excellence, precision, and a relentless drive to solve complex drug delivery challenges. The team at Kindeva is united by a shared purpose: to ensure that every patient, regardless of their condition, has access to the life-changing therapies they need.
Kindeva's culture is defined by a collaborative spirit that bridges the gap between early-stage feasibility and commercial-scale manufacturing. With a global network of state-of-the-art facilities, the company fosters an environment where experts in inhalation, transdermal, microneedle, and injectable technologies work side-by-side to push the boundaries of what is possible. This 'people-centric' approach empowers employees to innovate and take ownership of their work, knowing that their contributions directly impact patient health. Whether it is developing the next generation of green propellants for inhalers or pioneering microneedle-based delivery systems, the Kindeva team is driven by the knowledge that their work today creates a healthier, brighter future for tomorrow.
United States only